Document:

Resignation Letter Agreement dated May 14, 2009

 Exhibit 10.1 
 ULTRATECH, INC. 
 3050 ZANKER ROAD 
 SAN JOSE, CA 95134 
 May 14, 2009 
 Scott Jewler 
 Senior Vice President, Sales 
     and Marketing 
 Ultratech, Inc. 
 3050 Zanker Road 
 San Jose, CA 95134 
 Dear Scott 
 This letter will set forth the agreement we have reached
concerning your separation from service with Ultratech, Inc. (the “Company”). You have previously indicated your intention to resign from the Company, and your resignation date will accordingly occur at the close of business
on May 14, 2009 (the “Resignation Date”). On your Resignation Date, your employment with the Company will cease, you will no longer be an officer or employee of the Company, and your only remaining service relationship
with the Company will be pursuant to the limited consulting arrangement set forth below. Your Resignation Date will also constitute your separation from service date for purposes of Section 409A of the Internal Revenue Code of 1986, as amended
(the “Code”). 
 On your Resignation Date, the Company will pay you (i) any earned but unpaid base salary through that date,
(ii) any un-reimbursed business expenses for which you have submitted timely and appropriate documentation and (iii) an amount equal to your accrued but unpaid vacation pay (based on your current rate of base salary), subject to the
Company’s collection of all applicable withholding taxes. Effective as of your Resignation Date, you will cease to be entitled to any further employee benefits or perquisites from the Company, except as otherwise required by law, and you will
cease participation in all employee benefit plans of the Company, including (without limitation); (i) eligibility for participant contributions or Company-matching contributions under the Company’s 401(k) plan, (ii) any additional
accrual of vacation pay, sick leave or other paid time-off, (iii) eligibility for any equity awards or other stock-based compensation under the Company’s equity incentive plans or participation in the Company’s management incentive
plan or other bonus programs and (iv) participation in the Company’s group health care, life insurance and disability insurance plans. However, you will be entitled to exercise your COBRA rights to obtain continued health care coverage for
yourself and your spouse and eligible dependents under the Company’s group health plans, but all such continuation coverage shall be at your sole cost and expense. 

 You hereby agree that your outstanding equity awards and deferred compensation account will be treated as follows,
notwithstanding any provision to the contrary in the award agreements or other documentation governing those awards or account: 
 Option Grant: You currently hold an outstanding option granted to you on December 13, 2007 to purchase 75,000 shares of the Company’s common stock at an exercise price of $11.79 per share (the
“Option”). As of May 8, 2009, the Option was vested and exercisable as to 22,500 shares of the Company’s common stock, and no further vesting under that option will occur between May 8, 2009 and your
Resignation Date. You will have a three (3)-month period measured from your Resignation Date in which to exercise that Option for any or all of those 22,500 vested shares. Upon the expiration of that three (3)-month period, the Option will terminate
and cease to exercisable for those vested shares. On your Resignation Date, the Option will immediately terminate and cease to be outstanding for the remaining 52,500 shares of the Company’s common stock that were unvested as of May 8,
2009. 
 Restricted Stock Units. You currently hold the following restricted stock unit awards: 
  

			
	 Award Date
	  	Number of Restricted Stock Units
	 December 13, 2007
	  	10,000
	 February 2, 2009
	  	  6,000
	 April 20, 2009
	  	  6,000

 On your Resignation Date, you will be vested in 3,333 of your restricted stock units pursuant to
the various vesting schedules applicable to those units. Accordingly, on the first business day of the seventh month following your Resignation Date (the delayed issuance is required under Code Section 409A by reason of your current executive
officer status), 3,333 shares of the Company’s common stock will become issuable to you under those vested units. However, a portion of those issuable shares will automatically be withheld by the Company in satisfaction of the applicable
federal and state income and employment withholding taxes, and you will be issued only the net number of shares remaining after such withholding. On your Resignation Date, your 18,667 unvested restricted stock units will be immediately cancelled,
and you will cease to have any right or entitlement to receive any shares of the Company’s common stock under those cancelled units. 
 Deferred Compensation Account. As a result of your participation in the Company’s 2008 Management Incentive Plan, a deferred account balance in the principal amount of $68,000 was established for you. That account was to
vest and become payable in annual installments over a three (3)-year period and was to be credited with interest until paid. However, none of the account balance will be vested on your Resignation Date, and you will accordingly forfeit all your
right, title and interest in and to this account on your Resignation Date. 
 You previously received special bonus advances in the aggregate amount of
$555,500 during the 2008 calendar year which were reportable as part of your W-2 taxable wages for such year and subject to applicable withholding taxes. However, those advances are subject to repayment upon your termination of employment, to the
extent you have not otherwise vested in them. Under the applicable vesting schedule, you have to date vested in one-fourth of your aggregate bonus advances, and on your Resignation Date, $416,625 will remain unvested and subject to repayment. The
Company will, however, cancel your repayment obligation, if you comply with the following requirement: 
 - You render up to
10 hours of consulting services per month without any additional compensation (other than reimbursement of pre-approved out-of-pocket expenses) during the one-year period measured from your Resignation Date. Accordingly, on or before your
Resignation Date, you will sign and deliver to the Company the Consulting Agreement in the form attached as Exhibit A to this letter agreement. If you fulfill such consulting requirement, then your repayment obligation with respect to the bonus
advances will be cancelled at the end of the one-year consulting period. 
  

 2 

 No other severance benefits will be payable to you in connection with your voluntary resignation. 
 On or before your Resignation Date, you must return to the Company all tangible property of the Company in your possession, custody or control, including (without
limitation) your Company-owned laptop computer and peripheral devices, all originals and copies of all documents and materials, of whatever nature, relating to the Company, its products and/or its services, including (without limitation) all
datasheets, files, memoranda, emails, records, software, disks, instructional manuals and other physical or personal property that you received, prepared or helped prepare in connection with your employment with the Company. Except for documents or
materials in the public domain, you must not keep any paper or electronic copies or excerpts of any of the above items, and you hereby confirm and acknowledge that you have no proprietary or other interest in such documents and materials. In
addition, you shall continue to abide by the provisions and obligations in effect for you under your Proprietary Information and Inventions Agreement with the Company, to the extent those provisions and obligations continue by their terms in force
and effect beyond your termination of employment with the Company. 
 The Company strongly recommends that you obtain independent tax advice with respect to
the potential tax consequences relating to the various transactions set forth in this letter agreement, and your execution of this letter agreement will accordingly acknowledge and confirm that you have had the opportunity to obtain the necessary
tax advice for you to understand the appropriate tax treatment of those transactions and that you have entered into this letter agreement with full knowledge of the applicable tax consequences. 
 Kindly indicate your agreement with the terms and provisions of this letter agreement by signing and dating the enclosed duplicate original and returning it to Dave
Holmes by May 18, 2009. 
  

 3 

 We appreciate the services you have rendered the Company during your period of employment and the contribution you have
made to the Company’s success. We wish you continued success in your new endeavors and look forward to the continuing relationship we will have under the Consulting Agreement. 
  

			
	Very truly yours,
	
	 /s/    Dave Holmes

	Title:	 	SR VP HR

 AGREED TO AND ACCEPTED BY: 
  

	
	 /s/    Scott Jewler

	SCOTT JEWLER

 DATED: May 14, 2009 
  

 4 

 EXHIBIT A 
 FORM OF CONSULTING AGREEMENTEmployment Agreement

 Exhibit 10.1 
  
 EMPLOYMENT AGREEMENT 
 This Employment
Agreement (the “Agreement”) is entered into on May 20, 2009, by and between Francis J. Martin (the “Executive”) and NMT Medical, Inc., a Delaware corporation (the “Company”). 
 WHEREAS, the Company wishes to employ the Executive as the President and Chief Executive Officer of the Company under the terms and conditions set forth
below; and 
 WHEREAS, the Executive wishes to accept such employment under those terms and conditions; 
 NOW, THEREFORE, in consideration of the provisions and mutual covenants contained in this Agreement and for other good and valuable consideration, the
Parties agree as follows: 
  

	 	1.	TERM OF EMPLOYMENT. 

 The Company agrees to employ
the Executive, and the Executive agrees to serve, on the terms and conditions of this Agreement, for a period commencing as of April 14, 2009 and ending on April 13, 2010, or such shorter period as may be provided for herein, and such term
shall be automatically extended by successive additional one-year terms in the event that the Company fails to provide written notice of non-renewal of the Agreement to the Executive in accordance with Section 24 not later than 180 days prior
to the expiration of the then-current employment term (each an “Extension”). The employment term described above, including any Extension, is hereinafter referred to as the “Employment Term”. 
  

	 	2.	POSITION, DUTIES, RESPONSIBILITIES. 

 During the
Employment Term, the Executive shall serve as President and Chief Executive Officer of the Company. In such capacity, the Executive shall report to the Board of Directors of the Company (the “Board of Directors”) and shall perform such
duties and have such responsibilities of an executive nature as are set forth in the Company’s Amended and Restated By-Laws, as amended from time to time (the “By-Laws”), and as are customarily performed by a person holding such
office, it being recognized that the Executive’s specific duties and responsibilities, consistent with his titles hereunder, may be changed by the Board of Directors from time to time consistent with those overall duties customarily performed
by a person holding such office. The Executive shall devote his full business time and attention to the performance of his duties under this Agreement; provided, however, that the Executive shall be permitted to serve as a director on up to two
boards of directors in addition to the Board of Directors. In addition, during the Employment Term, the Executive shall serve without additional compensation as a director of the Company and on any committees of the Board of Directors, if requested,
subject to the terms of the By-Laws and to the approval of the stockholders of the Company to the extent required by applicable law and the By-Laws. 
  

	 	3.	BASE SALARY. 

 During the Employment Term and
effective as of April 14, 2009, the Executive shall be paid base salary at the annualized rate of $260,000 (“Salary”), subject to deductions for income taxes, social security, state payroll and unemployment and all other legally
required or authorized deductions and withholding. The Executive’s Salary shall be payable in accordance with the Company’s standard payroll practice. The Joint Compensation and Options Committee of the Board of Directors (the
“Compensation Committee”) shall review and establish the Executive’s Salary at least on an annual basis. 

	 	4.	STOCK OPTIONS. 

 (a) On the date of this Agreement,
the Executive shall be granted two stock options. One such option (the “Initial Option”) will be a stock option to purchase 60,000 shares of common stock, par value $.001 per share, of the Company (the “Common Stock”), under
either the Company’s 2001 Stock Incentive Plan, as amended (the “2001 Plan”), or the Company’s 2007 Stock Incentive Plan, as amended (the “2007 Plan”) and subject to the terms of the applicable plan and related option
agreement between the Executive and the Company. The exercise price for the Initial Option shall be the closing sale price of the Common Stock on the date of grant, as specified in the 2001 Plan or 2007 Plan, as applicable. This option shall, to the
maximum extent permissible under Section 422 of the Internal Revenue Code of 1986 (the “Code”), as amended, constitute an incentive stock option, with any balance of such option to be treated as a non-statutory stock option. The
Initial Option shall vest in 48 equal monthly installments on each monthly anniversary of the date of grant. The Initial Option shall have a term of ten (10) years from the date of grant, subject to the terms of the applicable plan and related
option agreement and Sections 13 and 15 of this Agreement. Notwithstanding the foregoing, the Initial Option shall become immediately exercisable in the event of a Change of Control of the Company or the termination of the Executive’s
employment without cause pursuant to Section 13. For purposes of this Agreement, a “Change of Control of the Company” shall be deemed to have occurred only upon (a) any merger or consolidation of the Company with or into another
entity as a result of which the Common Stock is converted into or exchanged for the right to receive cash, securities or other property, (b) any exchange of all or substantially all shares of the Company for cash, securities or other property
pursuant to a statutory share exchange transaction, or (c) sale or other disposition of all or substantially all of the assets of the Company. 
 (b) The second stock option (the “Performance Option,” and together with the Initial Option, the “Options”) to be granted to the Executive on the date of this Agreement will be a stock option to purchase 120,000 shares
of Common Stock, under either the 2001 Plan or 2007 Plan and subject to the terms of the applicable plan and related option agreement between the Executive and the Company. The exercise price for the Performance Option shall be the closing sale
price of the Common Stock on the date of grant, as specified in the 2001 Plan or 2007 Plan, as applicable. The Performance Option shall, to the maximum extent permissible under the Code, as amended, constitute an incentive stock option, with any
balance of such option to be treated as non-statutory stock options. The Performance Option shall have a term of ten (10) years from the date of grant, subject to the terms of the applicable plan and related option agreement and Sections 13 and
15 of this Agreement. Notwithstanding the foregoing, the Initial Option shall become immediately exercisable in the event of a Change of Control of the Company or the termination of the Executive’s employment without cause pursuant to
Section 13. 
  

 2 

	 	5.	ANNUAL BONUS. 

 Commencing with the Company’s
fiscal year ended December 31, 2009, after the completion of the Company’s fiscal year and as soon as the Company’s financial information required to be included in its Annual Report on Form 10-K for such fiscal year is available, but
in no event later than 90 days after the end of such fiscal year, the Executive shall be eligible to receive an annual bonus (the “Annual Bonus”) in an amount of up to $25,000 in cash, with the exact amount of such Annual Bonus, if any, to
be determined by the Board of Directors, in its sole discretion, after consultation with the Compensation Committee and/or the Executive, as the Board of Directors deems appropriate, on an annual basis. In the event that the Board of Directors
determines that the Executive is entitled to the Annual Bonus for a given fiscal year, then the Executive shall be paid the Annual Bonus not later than the date on which the Company files its Annual Report on Form 10-K for such fiscal year, but in
no event later than two and a half months following the end of such fiscal year. 
  

	 	6.	EMPLOYEE BENEFITS. 

 (a) Benefit Programs.
During the Employment Term, the Company shall provide the Executive and eligible family members with medical, dental, and disability insurance and such other benefits and perquisites as are provided in the Company’s applicable plans and
programs to its employees generally; provided, that the Executive meets the qualifications therefor (“Benefits”). 
 (b)
Vacation. During each twelve month period of the Employment Term, the Executive shall be entitled to four weeks of vacation; provided, however, that any vacation time not taken during any year shall be forfeited. The Executive shall also be
entitled to all paid holidays given by the Company to its officers and employees. 
 (c) Car Expenses. The Company will provide a
monthly automobile allowance of $750, which amount shall be paid to the Executive pursuant to the Company’s standard payroll practices. 
 (d) Continued Benefits. In the event the Employment Term is terminated due to Disability (as defined below) pursuant to Section 12, due to the termination of the Executive by the Company without Cause (as defined below) pursuant
to Section 13 or by the Executive without cause pursuant to Section 15, normal employee medical and dental insurance benefits shall be continued on an insured basis for the Executive and eligible family members for a period of 12 months
following the month in which the Termination Date (as defined below) occurs. 
  

	 	7.	REPRESENTATIONS AND WARRANTIES OF THE EXECUTIVE. 

 The Executive represents and warrants to the Company that the Executive is under no contractual or other restriction or obligation which is inconsistent with the execution of this Agreement, the performance of his duties hereunder, or the
other rights of the Company hereunder. 
  

 3 

	 	8.	NON-COMPETITION; NON-SOLICITATION. 

 In view of the
unique and valuable services it is expected Executive will render to the Company, Executive’s knowledge of the customers, trade secrets, and other proprietary information relating to the business of the Company and its customers and suppliers
and similar knowledge regarding the Company it is expected Executive will obtain, and in consideration of the compensation to be received hereunder, Executive agrees that he will not, during the period he is employed by the Company under this
Agreement or otherwise, and for a period of one year after he ceases to be employed by the Company under this Agreement or otherwise, compete with or be engaged in, or Participate In (as defined below) any other business or organization (which shall
not include a university, hospital, or other non-profit organization) which during such one year period is or as a result of the Executive’s engagement or participation would become competitive with the Company’s business of designing,
developing, manufacturing, marketing and selling medical devices designed to address cardiac structural defects that are being designed, developed, manufactured, marketed or sold by the Company up to the time of such cessation; provided, however,
that the provisions of this Section 8 shall not be deemed breached merely because the Executive owns less than 1% of the outstanding capital stock of a corporation, if, at the time of its acquisition by the Executive such stock is listed on a
national securities exchange. The term “Participate In” shall mean: “directly or indirectly, for his own benefit or for, with or through any other person (including the Executive’s immediate family), firm or corporation, own,
manage, operate, control, loan money to, or participate in the ownership, management, operation or control of, or be connected as a director, officer, employee, partner, consultant, agent, independent contractor, or otherwise with, or acquiesce in
the use of his name in.” 
 The Executive will not, directly or indirectly, solicit or interfere with, or endeavor to entice away from
the Company any of its suppliers, customers or employees within a period of one year after the date of termination of the Executive’s employment (the “Termination Date”). The Executive will not directly or indirectly employ any person
who was an employee of the Company within a period of one year after such person leaves the employ of the Company. 
 If any restriction
contained in this Section 8 shall be deemed to be invalid, illegal, or unenforceable by reason of the extent, duration or geographical scope thereof, or otherwise, then the court making such determination shall have the right to reduce such
extent, duration, geographical scope or other provisions hereof, and in its reduced form such restriction shall then be enforceable in the manner contemplated hereby. 
  

	 	9.	INTELLECTUAL PROPERTY RIGHTS. 

 Any interest in
patents, patent applications, inventions, technological innovations, copyrights, copyrightable works, developments, discoveries, designs and processes which the Executive during the period he is employed by the Company under this Agreement or
otherwise may acquire, conceive of or develop, either alone or in conjunction with others, utilizing the time, material, facilities or information of the Company (“Inventions”) shall belong to the Company; as soon as the Executive owns,
conceives of, or develops any Invention, he agrees immediately to communicate such fact in writing to the Board of Directors, and without further compensation, but at the Company’s expense, forthwith upon request of the Company, the 

  

 4 

 
Executive shall execute all such assignments and other documents (including applications for patents, copyrights, trademarks, and assignments thereof) and
take all such other action as the Company may reasonably request in order (a) to vest in the Company all of the Executive’s right, title and interest in and to such Inventions, free and clear of liens, mortgages, security interests,
pledges, charges and encumbrances and (b), if patentable or copyrightable, to obtain patents or copyrights (including extensions and renewals) therefor in any and all countries in such name as the Company shall determine. 
  

	 	10.	NONDISCLOSURE. 

 The Employee Nondisclosure
Agreement dated as of April 14, 2009, between the Company and the Executive shall remain in full force and effect. 
  

	 	11.	INJUNCTIVE RELIEF. 

 Because a breach of the
provisions of any of Section 8, Section 9 and Section 10 could not adequately be compensated by money damages, the Company shall be entitled, in addition to any other right and remedy available to it, to an injunction restraining such
breach or a threatened breach, and in either case no bond or other security shall be required in connection therewith. The Executive agrees that the provisions of each of Section 8, Section 9 and Section 10 are necessary and
reasonable to protect the Company in the conduct of its business. 
  

	 	12.	TERMINATION OF THE EXECUTIVE UPON DEATH OR DISABILITY. 

 (a) The Employment Term shall terminate automatically upon the Executive’s death. In addition, the Company shall have the right to terminate the Employment Term upon the Disability (as defined below) of the Executive. If the
Executive’s employment is terminated by the Company due to the Executive’s death or Disability, then, subject to Section 17, the Executive, his guardian or his estate, as applicable, shall be entitled to: 
  

	 	 (i)
	 Salary and Benefits earned to the Termination Date (i) if by reason of Disability, the date being the
30th day after Executive’s receipt of a physician’s certification of Disability, unless before such date, the Executive shall have resumed
the full time performance of the Executive’s duties, or (ii) if by reason of the Executive’s death, on the Executive’s date of death, in either case, payable within 30 days of the Termination Date; 

 

	 	(ii)	Continued benefits pursuant to Section 6(d); and 

  

	 	(iii)	Other benefits as are provided under the applicable plans and programs of the Company as then in effect. 

 (b) For purposes of this Agreement, “Disability” shall mean any physical or mental disability or incapacity that renders the Executive
incapable of performing his duties hereunder for a period of 180 consecutive calendar days or for shorter periods aggregating 180 calendar days during any consecutive twelve-month period. 
  

 5 

	 	13.	INVOLUNTARY TERMINATION WITHOUT CAUSE. 

 (a) The
Executive shall be deemed to have been involuntarily terminated without Cause (as defined below) if one of the following events occurs: 
  

	 	(i)	The Company terminates the Executive’s employment at anytime without Cause (as defined below); 

  

	 	(ii)	There occurs a reduction by the Company in the Executive’s responsibilities, authorities, powers and duties from the responsibilities, authorities, powers and duties exercised
by the Executive just prior to such reduction but excluding such reduction effected with the Executive’s prior consent or for reasons arising out of the Executive’s gross negligence or willful misconduct; 

  

	 	(iii)	The Company requires the Executive to be based principally at any office or location which is outside of the Greater Boston area, unless the Executive consents to be based
principally at such other office or location; 

  

	 	(iv)	The Company’s failure to (x) maintain the Executive’s eligibility for participation in existing benefit plans then being made available by the Company to other
employees of the Company having substantially similar levels of responsibility as the Executive or (y) provide to the Executive substantially the same benefits or other perquisites then being provided or paid to the other employees of the
Company having substantially similar levels of responsibility as the Executive; 

  

	 	(v)	There occurs a breach of this Agreement by the Company which continues for more than seven (7) business days after the Executive gives written notice to the Company, setting
forth in reasonable detail the nature of such breach; or 

 (vi) Causing or requiring the Executive to report
to anyone other than the Chairman of the Board and/or the Board of Directors. 
 (b) If the Executive’s employment is involuntarily
terminated at any time without Cause (as defined below), the Executive shall be entitled to: 
  

	 	(i)	Salary and Benefits earned to the Termination Date; 

  

	 	(ii)	Continued benefits pursuant to Section 6(d); and 

  

	 	(iii)	Continued Salary for a period of twelve months from the Termination Date. 

  

 6 

 In addition, the then-exercisable portion of each of the Initial Option and the Performance Option shall
remain exercisable for a period of one (1) year after the Termination Date. 
  

	 	14.	TERMINATION BY THE COMPANY FOR CAUSE. 

 (a)
GENERAL. The Company shall have the right to terminate the Executive’s employment for Cause, as defined in subsection (b) below, in which event, the Executive shall be entitled only to Salary and Benefits earned to the Termination
Date, payable within 30 days of the Termination Date. The Board of Directors may not terminate the Executive’s employment for Cause unless the Board of Directors makes a good faith determination that the Executive’s employment should be
terminated for Cause because the acts or omissions alleged to constitute Cause did in fact occur and do constitute Cause as defined in this Agreement. In addition, all exercisable Options shall expire and no longer be exercisable as of the
Termination Date. 
 (b) CAUSE. For purposes of this Agreement, “Cause” shall mean: 
  

	 	(i)	fraud, embezzlement or gross insubordination on the part of the Executive; 

  

	 	(ii)	conviction of or the entry of a plea of nolo contendere by the Executive to any felony or crime of moral turpitude; 

  

	 	(iii)	a material breach of, or the willful failure or refusal by the Executive to perform and discharge, his duties, responsibilities or obligations under this Agreement that is not
corrected within 20 days following written notice thereof to the Executive by the Company, such notice to state with specificity the nature of the breach, failure or refusal; provided, that if such breach, failure or refusal cannot reasonably be
corrected within 20 days of written notice thereof, correction shall be commenced by the Executive within such period and shall be corrected as soon as practicable thereafter; or 

  

	 	(iv)	any act of willful misconduct by the Executive which is intended to result in substantial personal enrichment of the Executive at the expense of the Company or any of its
subsidiaries or affiliates. 

 For purposes of clause (b)(iii) or (iv), Cause shall not include anyone or more of the
following: 
  

	 	(i)	bad judgment; 

  

	 	(ii)	negligence; or 

  

	 	(iii)	any act or omission that the Executive believed in good faith to have been in or not opposed to the interest of the Company. 

  

 7 

 15. TERMINATION BY THE EXECUTIVE WITHOUT CAUSE. The Executive may terminate this Agreement at any
time with or without cause by providing thirty (30) days’ prior written notice to the Company, in which event, the Executive shall be entitled only to Salary and Benefits earned to the Termination Date, payable within 30 days of the
Termination Date, and continued benefits pursuant to Section 6(d). In addition, the then-exercisable portion of each of the Initial Option and the Performance Option shall remain exercisable for a period of one (1) year after the
Termination Date. 
  

	 	16.	WITHHOLDING. 

 Anything to the contrary
notwithstanding, all payments required to be made by the Company under this Agreement to the Executive, his spouse, his estate or beneficiaries, shall be subject to withholding of such amounts relating to taxes as the Company may reasonably
determine it should withhold pursuant to any applicable law or regulation. In addition, in the event that the Company reasonably determines that it is required to make any payments of withholding taxes as a result of Executive’s receipt of any
other income pursuant to the terms of this Agreement, the Company may, as a condition to such receipt, require that the Executive provide the Company with an amount of cash sufficient to enable the Company to pay such withholding taxes. 

17. COMPLIANCE WITH SECTION 409A. Subject to the provisions in this Section 17, any severance payments or benefits under this Agreement
shall begin only upon the date of the Executive’s “separation from service” (determined as set forth below) which occurs on or after the Termination Date. The following rules shall apply with respect to distribution of the payments
and benefits, if any, to be provided to the Executive under this Agreement. 
 (a) It is intended that each installment of the severance
payments and benefits provided under this Agreement shall be treated as a separate “payment” for purposes of Section 409A of the Code and the guidance issued thereunder (“Section 409A”). Neither the Executive nor the Company
shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent specifically permitted or required by Section 409A. 
 (b) If, as of the date of the Executive’s “separation from service” from the Company, the Executive is not a “specified employee” (within the meaning of Section 409A), then each
installment of the severance payments and benefits shall be made on the dates and terms set forth in this Agreement. 
 (c) If, as of the
date of the Executive’s “separation from service” from the Company, the Executive is a “specified employee” (within the meaning of Section 409A), then: 
  

	 	(i)	Each installment of the severance payments and benefits due under this Agreement that, in accordance with the dates and terms set forth herein, will in all circumstances, regardless
of when the separation from service occurs, be paid within the short-term deferral period (as defined in Section 409A) shall be treated as a short-term deferral within the meaning of Treasury Regulation Section 1.409A-1(b)(4) to the
maximum extent permissible under Section 409A; and 

  

 8 

	 	(ii)	Each installment of the severance payments and benefits due under this Agreement that is not described in Section 17(c)(i) above and that would, absent this subsection, be paid
within the six-month period following the Executive’s “separation from service” from the Company shall not be paid until the date that is six months and one day after such separation from service (or, if earlier, the Executive’s
death), with any such installments that are required to be delayed being accumulated during the six-month period and paid in a lump sum on the date that is six months and one day following the Executive’s separation from service and any
subsequent installments, if any, being paid in accordance with the dates and terms set forth herein; provided, however, that the preceding provisions of this sentence shall not apply to any installment of severance payments and
benefits if and to the maximum extent that such installment is deemed to be paid under a separation pay plan that does not provide for a deferral of compensation by reason of the application of Treasury Regulation 1.409A-1(b)(9)(iii) (relating
to separation pay upon an involuntary separation from service). Any installments that qualify for the exception under Treasury Regulation Section 1.409A-1(b)(9)(iii) must be paid no later than the last day of the second taxable year following
the taxable year in which the separation from service occurs. 

 (d) The determination of whether and when the Executive’s
separation from service from the Company has occurred shall be made in a manner consistent with, and based on the presumptions set forth in, Treasury Regulation Section 1.409A-1(h). Solely for purposes of this Section 17(d),
“Company” shall include all persons with whom the Company would be considered a single employer as determined under Treasury Regulation Section 1.409A-1(h)(3). 
 (e) All reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with the requirements of
Section 409A to the extent that such reimbursements or in-kind benefits are subject to Section 409A, including, where applicable, the requirements that (i) any reimbursement is for expenses incurred during the Executive’s
lifetime (or during a shorter period of time specified in this Agreement), (ii) the amount of expenses eligible for reimbursement during a calendar year may not affect the expenses eligible for reimbursement in any other calendar year,
(iii) the reimbursement of an eligible expense will be made on or before the last day of the calendar year following the year in which the expense is incurred and (iv) the right to reimbursement is not subject to set off or liquidation or
exchange for any other benefit. 
  

 9 

	 	18.	LOCK-UP AGREEMENT. 

 In the event that the Company
seeks to consummate a public offering of its securities during the Employment Term, the Executive shall execute an agreement in a form and substance satisfactory to the managing underwriter or underwriters of the Company’s securities, not to
sell, pledge, contract to sell, grant any option or otherwise dispose of any shares of stock owned or acquired by the Executive for such period of time as requested by such underwriter of all other executive officers of the Company. 
  

	 	19.	INDEMNIFICATION. 

 During the Employment Term, the
Company agrees to (i) indemnify the Executive in his capacity as an officer of the Company and, to the extent applicable, as an officer and director of each subsidiary of the Company, as provided in Article Eighth of the Company’s Second
Amended and Restated Certificate of Incorporation, as amended, and (ii) use its best efforts to maintain in effect its director and officer liability insurance policies, providing for coverage of at least the amount in effect as of the date
written above. 
  

	 	20.	LEGAL FEES. 

 The Company shall reimburse the
Executive all reasonable and documented legal fees, costs and expenses incurred by the Executive in contesting or disputing any breach of this Agreement by the Company or in seeking to obtain or enforce any right or benefit provided by this
Agreement; provided, however, that the Company shall have no such obligation to reimburse the Executive for such legal fees, costs and expenses if the final resolution of such matter is determined by a court of competent jurisdiction to be in the
Company’s favor. 
  

	 	21.	ASSIGNABILITY; BINDING NATURE. 

 This Agreement and
all rights of the Executive shall inure to the benefit of and be enforceable by the Executive’s personal or legal representatives, estates, executors, administrators, heirs and beneficiaries. All amounts payable to the Executive hereunder shall
be paid, in the event of the Executive’s death, to the Executive’s estate, heirs and representatives. This Agreement shall inure to the benefit of, be binding upon, and be enforceable by, any successor, surviving or resulting company or
other entity to which all or substantially all of the Company’s business and assets shall be transferred. 
  

	 	22.	ENTIRE AGREEMENT. 

 This Agreement, together with
the Employee Nondisclosure and Secrecy Agreement, contains the entire agreement between the Executive and the Company (each, a “Party”) concerning the subject matter hereof and supersedes all prior agreements, understandings, discussions,
negotiations, and undertakings, whether written or oral, between the Parties with respect thereto, including without limitation the Prior Employment Agreement. The Prior Employment Agreement is hereby terminated and of no further force and effect.

  

 10 

	 	23.	AMENDMENTS AND WAIVERS. 

 This Agreement may not be
modified or amended except by a writing signed by both Parties. A Party may waive compliance by the other Party with any term or provision of this Agreement, or any part thereof, provided that the term or provision, or part thereof, is for the
benefit of the waiving Party. Any waiver will be limited to the facts or circumstances giving rise to the noncompliance and will not be deemed either a general waiver or modification with respect to the term or provision, or part thereof, being
waived, or as to any other term or provision of this Agreement, nor will it be deemed a waiver of compliance with respect to any other facts or circumstances then or thereafter occurring. 
  

	 	24.	NOTICE. 

 Any notice given under this Agreement
shall be in writing and shall be deemed given when delivered personally or by courier, or five days after being mailed, certified or registered mail, duly addressed to the Party concerned at the address indicated below or at such other address as
such Party may subsequently provide, in accordance with the notice and delivery provisions of this Section 24: 
  

			
	 (a)    If to the Company:
	  	 NMT Medical, Inc.
 27 Wormwood Street
 Boston, MA 02210
 Attn: Richard E. Davis

		
	          with a copy to:
	  	 Wilmer Cutler Pickering Hale and Dorr LLP
 60 State
Street
 Boston, MA 02109-1803
 Attn: Michael J. LaCascia, Esq.

  

	 	(b)	If to the Executive, at his address as it appears on the Company’s records. 

  

	 	25.	SEVERABILITY. 

 In the event that any provision or
portion of this Agreement shall be determined to be invalid or unenforceable for any reason, the remaining provisions or portions of this Agreement will be unaffected thereby and shall remain in full force and effect to the fullest extent permitted
by law. 
  

	 	26.	SURVIVORSHIP. 

 The respective rights and
obligations of the Parties hereunder shall survive any termination of this Agreement to the extent necessary to the intended preservation of such rights and obligations. 
  

 11 

	 	27.	REFERENCES. 

 In the event of the Executive’s
death or a judicial determination of his incompetence, reference in this Agreement to the Executive shall be deemed, where appropriate, to refer to his legal representative or, where appropriate, to his beneficiary or beneficiaries. 
  

	 	28.	GOVERNING LAW. 

 This Agreement shall be governed
by and construed and interpreted in accordance with the laws of The Commonwealth of Massachusetts without reference to the principles of conflicts of law. 
  

	 	29.	HEADINGS. 

 The headings of sections contained in
this Agreement are for convenience only and shall not be deemed to control or affect the meaning or construction of any provision of this Agreement. 
  

	 	30.	COUNTERPARTS AND FACSIMILE SIGNATURE. 

 This
Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. This Agreement may be executed by facsimile signature. 
 [Remainder of page intentionally left blank] 
  

 12 

 THE UNDERSIGNED have executed this Agreement effective as of the date first written above. 
  

			
	 COMPANY:
  
 NMT Medical, Inc.

		
	By:	 	/s/    Richard E. Davis
		 	 Richard E. Davis
 Chief Operating Officer

	
	 EXECUTIVE:
  

	
	/s/    Francis J. Martin
	Francis J. Martin

 SCHEDULE I 
 Vesting Schedule for Performance Option 
 The Performance Option to purchase 120,000 shares of Common
Stock granted to the Executive on the date of this Agreement pursuant to Section 4(b) of this Agreement shall vest as follows: 
  

			
	 Threshold Stock Price for Vesting
	  	 Portion of Stock Option Vesting

		
	On the day on which the Average Stock Price has been equal to or greater than $4.50, but less than $9.00.	  	1/2 of the stock option (60,000 shares of Common Stock)
		
	On the day on which the Average Stock Price has been equal to or greater than $9.00.	  	The remaining 1/2 of the stock option (60,000 shares of Common Stock)

 For purposes of this Agreement, “Average Stock Price” shall mean the per share closing price of the
Common Stock on the Nasdaq Global Market (or whatever successor market on which the Common Stock may then trade) for the immediately preceding 30 trading days. For purposes of clarity, to the extent that a portion of the Performance Option vests,
such portion shall remain vested and exercisable in accordance with its terms and shall not be affected by subsequent changes in Average Stock Price.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}]]